Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

CVKDCVKD
7 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in CADRENAL THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 19,024 shares of CVKD (CADRENAL THERAPEUTICS INC), worth $63,540 as of 2026-Q2. The position was decreased (-12.0% shares).

Current Value

$63,540

Current Shares

19,024

Total Value Change

-$89,386

Total Shares Change

+8,470

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
19,024
-12.0%
$63,5400.0%$3.34
0
2026-Q1
Increased
21,626
+48.9%
$110,7240.0%$8.13
21
2025-Q4
Increased
14,528
+14.3%
$98,4990.0%$6.62
17
2025-Q3
Unchanged
12,710
0.0%
$175,0790.0%$13.42
0
2025-Q2
Increased
12,710
+5.2%
$153,1540.0%$10.44
16
2025-Q1
Increased
12,086
+14.5%
$213,0750.0%$18.46
18
2024-Q4
New
10,554
-
$152,9260.0%$14.23
34

Other major holders of CVKD: VANGUARD GROUP INC, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used